| EAR30-70 (number of cases per 10,000 persons per year) | |||||
---|---|---|---|---|---|---|
3D-CRT | PT | |||||
Linear | Lin-exp | Lin-plat | Linear | Lin-exp | Lin-plat | |
Group 1 | ||||||
 Ipsilateral lung | 85 ± 18 | 27 ± 3 | 25 ± 3 | 44 ± 22 | 16 ± 7 | 14 ± 6 |
 Contralateral lung | 3 ± 1 | 3 ± 1 | 3 ± 1 | 1 ± 1 | 0 ± 1 | 0 ± 1 |
 Contralateral breast | 7 ± 3 | 6 ± 2 | 6 ± 2 | 0 ± 0 | 0 ± 0 | 0 ± 0 |
 | VMAT | PT | ||||
---|---|---|---|---|---|---|
Linear | Lin-exp | Lin-plat | Linear | Lin-exp | Lin-plat | |
Group 2—FB | ||||||
 Ipsilateral lung | 131 ± 17 | 40 ± 3 | 37 ± 3 | 63 ± 5 | 20 ± 3 | 18 ± 2 |
 Contralateral lung | 55 ± 8 | 35 ± 3 | 30 ± 2 | 2 ± 2 | 1 ± 1 | 1 ± 1 |
 Contralateral breast | 44 ± 6 | 35 ± 4 | 31 ± 3 | 0 ± 0 | 0 ± 0 | 0 ± 0 |
Group 2—DIBH | ||||||
 Ipsilateral lung | 108 ± 15 | 35 ± 3 | 33 ± 3 | 53 ± 11 | 20 ± 2 | 17 ± 2 |
 Contralateral lung | 46 ± 4 | 29 ± 2 | 25 ± 1 | 1 ± 0 | 1 ± 0 | 1 ± 0 |
 Contralateral breast | 43 ± 7 | 34 ± 5 | 31 ± 4 | 0 ± 0 | 0 ± 0 | 0 ± 0 |